clinicalomicsprowebdirectory
News
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Marketplace
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News
Bioinformatics
Genetic Variants Could Predispose Carriers To More Serious COVID-19 Infections
News & Features
Results from Large-Scale NSCLC Precision Medicine Trial Inform Future Trial Design
Cancer Testing
Canadian Consortium Backs Liquid Biopsy Solution to Increase Cancer Testing Access…
Bioinformatics
NHGRI Unveils Gapless Sequence of Human X Chromosome
Coronavirus
Moderna’s COVID-19 Vaccine Speeds to Phase III Trial After More Positive…
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Bioinformatics
Genetic Variants Could Predispose Carriers To More Serious COVID-19 Infections
Cancer Testing
Canadian Consortium Backs Liquid Biopsy Solution to Increase Cancer Testing Access…
Bioinformatics
NHGRI Unveils Gapless Sequence of Human X Chromosome
Coronavirus
Moderna’s COVID-19 Vaccine Speeds to Phase III Trial After More Positive…
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Marketplace
Multimedia
All
Webinars
eBooks
Upcoming Webinars
Integrating NGS and Optical Mapping to Resolve Focal Amplifications in Cancer
On Demand Webinars
Newborn Genomic Screening: In Sickness and In Health
eBooks
Clinical Research in a Real-Time Sequencing Age
Precision Medicine
From Bench to Clinic—The Potential of New Sequencing Tools
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Sample Preparation
Protein
Protein
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Protein
Missing Neural Progenitor Protein May Be Responsible for Autism Development
January 10, 2020
Protein
Epigenomic Packaging of Blood’s Cell-Free DNA Reveals Biological Age
December 31, 2018
Protein
Nobel in Chemistry Awarded for Directed Evolution of Enzymes and Antibodies
October 4, 2018
Protein
Algorithm Helps Find the Right Spot to Split a Protein for...
October 4, 2018
Protein
RUNX Proteins Integral to Efficient DNA Repair
August 16, 2018
Protein
Cancer-Linked Rearrangements Pepper Genome’s Regulatory Regions
July 11, 2018
Protein
NanoString Partners with Five CROs to Advance Quantification Platform
April 30, 2018
Protein
Exosome Diagnostics, Intezyne Partner on CDx for Cancer Treatment IT-139
March 16, 2018
Protein
Protein Domain Controls DNA Cutting, Making CRISPR More Accurate
September 22, 2017
Protein
Boehringer Ingelheim to Leverage Philogen’s DNA-Encoded Library Platform
July 21, 2017
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Epic Sciences said today its liquid biopsy blood test showed in a study that it can help physicians select prostate cancer patients who are likely to benefit from a Pfizer prostate-specific membrane antigen (PSMA)-targeted therapy candidate known as BIND-014 before the start of treatment. [Source: © Alex Tihonov/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1907-218x150.jpeg "Canadian Consortium Backs Liquid Biopsy Solution to Increase Cancer Testing Access During the Pandemic")
![Boehringer Ingelheim will apply Philogen’s Encoded Self-Assembling Chemical (ESAC) Library Technology in the companies' second drug discovery collaboration. [Theasis/iStock Photos]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1174-324x160.jpeg "Boehringer Ingelheim to Leverage Philogen’s DNA-Encoded Library Platform")
